GP88/PGRN IHC Control Slides

GP88/PGRN IHC Control Slides

250.00
Quantity:
Add To Cart

Technical Data

Product #
AG10012
Product name
Anti-GP88/PGRN IHC Control Slides
Desciption
Formalin Fixed Paraffin Embedded Cells
Quantity
5 Positive / 5 Negative

Applications

IHC       Yes

Working concentrations for your specific applications should be determined by the investigator. Appropriate concentrations will be affected by several factors, including secondary antibody affinity, antigen concentration, sensitivity of detection method, temperature, and length of incubations, etc.

Handling Requirements

Storage
Store at -20°C. Avoid repeated freezing and thawing.

References

Progranulin (GP88) tumor tissue expression is associated with increased risk of recurrence in breast cancer patients diagnosed with estrogen receptor positive invasive ductal carcinoma. Ginette Serrero, Douglas M Hawkins, Binbin Yue, Olga Ioffe, Pablo Bejarano, Jeffrey T Phillips, Jonathan F Head, Robert L Elliott, Katherine R Tkaczuk, Andrew K Godwin, JoEllen Weaver, Wes E Kim Breast Cancer Research 2012, 14:R26 (8 February 2012)

IHC

Anti-GP88/PGRN recognizes Progranulin expressing cells.

Negative Control Slide

GP88/PGRN Non-Expressing Cells

GP88/PGRN Non-Expressing Cells

Positive Control Slide

GP88/PGRN Expressing Cells

GP88/PGRN Expressing Cells

GP88/PGRN Names

GP88/PGRN is also known as Progranulin, PC cell-derived growth factor (PCDGF), granulin-epithelin, acrogranin, GEP, PEPI, proepithelin.

Intellectual Property

This antibody is subject to Intellectual Property and owned exclusively by A&G Pharmaceutical, Inc.